CAHTALYST Trademark

Trademark Overview


On Friday, October 23, 2020, a trademark application was filed for CAHTALYST with the United States Patent and Trademark Office. The USPTO has given the CAHTALYST trademark a serial number of 90273958. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, May 6, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The CAHTALYST trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information; excluding medical information in the field of ophthalmology

Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology
cahtalyst

General Information


Serial Number90273958
Word MarkCAHTALYST
Filing DateFriday, October 23, 2020
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Description of MarkThe mark consists of the word "CAHtalyst" in yellow to the right of a yellow circle with white and blue arches inside of it.
Pseudo MarkCATALYST
Indication of Colors claimedThe color(s) yellow, white and blue is/are claimed as a feature of the mark.
Goods and ServicesProviding medical information; excluding medical information in the field of ophthalmology
Goods and ServicesPharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, December 15, 2020ASSIGNED TO EXAMINER
Tuesday, October 27, 2020NEW APPLICATION ENTERED
Saturday, December 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 15, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 23, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 23, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021SUSPENSION LETTER WRITTEN
Thursday, July 22, 2021LETTER OF SUSPENSION E-MAILED
Thursday, July 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 22, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, April 5, 2022SUSPENSION INQUIRY WRITTEN
Tuesday, April 5, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, April 5, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 4, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 21, 2022ASSIGNED TO LIE
Tuesday, November 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 9, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 8, 2023SOU EXTENSION 1 FILED
Wednesday, November 8, 2023SOU EXTENSION 1 GRANTED
Friday, November 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024SOU EXTENSION 2 GRANTED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 6, 2024SOU EXTENSION 2 FILED